Anaconda
Anaconda Price range: $ 87,00 through $ 225,00
Back to products
Androxal
Androxal Price range: $ 55,00 through $ 99,00

Anafranil

Price range: $ 41,00 through $ 457,00

Anafranil is a highly effective tricyclic antidepressant primarily indicated for the treatment of obsessive-compulsive disorder (OCD). The medication works by restoring the balance of natural substances like serotonin in the brain to help regulate mood and behavior. It is specifically designed to reduce persistent, intrusive thoughts and the repetitive behaviors that often disrupt daily functioning. In addition to managing OCD, Anafranil is utilized to alleviate symptoms associated with various depressive disorders. Consistent use of this medication helps patients achieve greater mental stability and improves overall daily well-being.

Active substance: Clomipramine
SKU: Anafranil Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Anafranil belongs to a class of medications known as tricyclic antidepressants (TCAs). Prescribed under strict medical supervision, it plays a primary role in managing specific psychiatric conditions, most notably obsessive-compulsive disorder (OCD). In the United States, Anafranil is classified as a prescription-only (Rx) medication, requiring evaluation and continuous oversight by a licensed healthcare professional.

Because this medication alters neurochemical balances within the central nervous system, understanding its pharmacologic profile, proper dosing, and safety considerations is essential. The following details provide a comprehensive reference for patients, caregivers, and clinical practitioners managing treatment with Anafranil.

Anafranil – Information for Patients and Caregivers

Parameter Details
Active ingredient Clomipramine hydrochloride
Therapeutic class Tricyclic antidepressant (TCA)
Dosage form Oral capsule (25 mg, 50 mg, 75 mg)
Route of administration Oral
Primary purpose Management of Obsessive-Compulsive Disorder (OCD)
Prescription status Prescription-only (Rx)

Main uses

The primary indication approved by the U.S. Food and Drug Administration (FDA) for Anafranil is the treatment of obsessive-compulsive disorder (OCD) in adults and pediatric patients aged 10 years and older. The medication helps diminish the persistent, unwanted thoughts (obsessions) and repetitive behaviors (compulsions) characteristic of this condition.

In clinical practice, healthcare providers may occasionally evaluate Anafranil for off-label indications. These off-label applications–which are not officially FDA-approved indications–include severe major depressive disorder, panic disorder, cataplexy associated with narcolepsy, and certain chronic pain syndromes. Any off-label use must be specifically directed and monitored by a qualified prescriber.

How the drug works

Anafranil exerts its therapeutic influence primarily by inhibiting the presynaptic reuptake of the neurotransmitters serotonin (5-HT) and norepinephrine (NE) in the brain. Compared to other tricyclic agents, clomipramine demonstrates a potent and relatively selective inhibition of serotonin reuptake.

Once absorbed, clomipramine is metabolized into its primary active compound, desmethylclomipramine (norclomipramine), which preferentially inhibits norepinephrine reuptake. Together, these substances increase neurochemical availability within the synaptic cleft. Additionally, Anafranil exhibits antagonist activity at muscarinic acetylcholine receptors, histamine H1 receptors, and alpha-1 adrenergic receptors, which accounts for both its therapeutic effects and its secondary side effect profile.

Dosing schedule

Dosing for Anafranil must be individualized based on clinical response, tolerability, and age. Treatment typically initiates at a lower daily dose–often 25 mg daily for adults–to reduce initial gastrointestinal and anticholinergic side effects. The dose is then gradually titrated over several weeks under medical oversight.

For adult patients, the maximum recommended daily dosage is 250 mg per day. For pediatric patients (ages 10 and older), the dose is calculated based on body weight, with a maximum cap of 3 mg/kg per day or 200 mg per day, whichever is less. During the initial titration phase, total daily doses are often divided and taken with meals to minimize stomach upset. Once a stable maintenance dose is reached, the prescriber may direct the patient to take the total daily dose at bedtime to minimize daytime drowsiness.

What happens in the body

Following oral administration, clomipramine hydrochloride is rapidly and completely absorbed from the gastrointestinal tract. However, due to significant hepatic first-pass metabolism, its systemic bioavailability is approximately 50%. Peak plasma concentrations of clomipramine are generally achieved within 2 to 6 hours post-dose.

Clomipramine is extensively bound to plasma proteins (approximately 97% to 98%). The elimination half-life of parent clomipramine ranges from 19 to 37 hours, whereas the active metabolite, norclomipramine, exhibits a longer elimination half-life ranging from 54 to 77 hours. Metabolism occurs extensively in the liver via cytochrome P450 enzymes, specifically CYP2D6, CYP1A2, and CYP2C19. Excretion of metabolites occurs through both renal (urine) and biliary pathways.

First days of treatment

Patients beginning therapy with Anafranil should be aware that therapeutic benefits are rarely immediate. While some physiological changes occur early, meaningful reduction in obsessive thoughts or compulsive behaviors often requires 2 to 4 weeks–and sometimes up to 8 to 12 weeks–of consistent daily use at an adequate therapeutic dose.

During the first few days or weeks of treatment, patients are more likely to experience mild to moderate side effects, such as dry mouth, drowsiness, lightheadedness, or nausea. These early symptoms often diminish as the body adapts to the medication. Sudden discontinuation should be avoided, as dosage adjustments must be conducted gradually under medical direction.

Food and alcohol interactions

Taking Anafranil capsules with food or immediately after a meal can significantly reduce gastrointestinal discomfort, such as nausea or abdominal irritation, particularly during the initial dosing phase.

Alcohol consumption must be strictly avoided during treatment with Anafranil. Ethanol enhances the central nervous system depressant effects of tricyclic antidepressants, leading to profound drowsiness, impaired motor coordination, severe cognitive slowdown, and an elevated risk of accidental injury or overdose.

What not to combine

Anafranil has a significant potential for serious interactions with numerous therapeutic agents. Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the high risk of severe, potentially fatal Serotonin Syndrome or hyperpyretic crises. A minimum washout period of 14 days must be observed between stopping an MAOI and starting Anafranil, or vice versa.

Other notable medication interactions include:

  • Selective Serotonin Reuptake Inhibitors (SSRIs) and SNRIs: May lead to dangerous serotonin accumulation and increased clomipramine plasma levels via CYP2D6 inhibition.
  • CYP2D6 or CYP1A2 inhibitors (e.g., fluoxetine, paroxetine, cimetidine): Elevate plasma concentrations of Anafranil, increasing the risk of toxicity.
  • Anticholinergic drugs: Produce additive anticholinergic effects, heightening risks of severe constipation, urinary retention, and confusion.
  • Antihypertensive agents: May alter blood pressure control or exacerbate orthostatic hypotension.
  • CNS Depressants (sedatives, opioids, hypnotics): Potentiate sedating effects and respiratory depression.

Adverse reactions

Adverse events associated with Anafranil often stem from its anticholinergic, antihistaminic, and antiadrenergic properties. The frequency and intensity of side effects are generally dose-dependent.

Commonly reported adverse effects include:

  • Dry mouth and altered taste perception
  • Somnolence, sedation, and fatigue
  • Constipation and delayed gastrointestinal motility
  • Dizziness and orthostatic hypotension (drop in blood pressure upon standing)
  • Weight gain and increased appetite
  • Tremors, sweating, and blurred vision (accommodation disturbances)
  • Sexual dysfunction, including impaired libido, erectile dysfunction, and delayed ejaculation

Less common but severe reactions include urinary retention, confusion, cardiac dysrhythmias, increased intraocular pressure, and lowered seizure threshold.

Important precautions

Boxed Warning: Suicidality and Antidepressant Drugs. Antidepressants, including Anafranil, increased the risk of suicidal thoughts and behaviors in children, adolescents, and young adults in short-term studies of major depressive disorder and other psychiatric disorders. Patients of all ages started on therapy should be monitored closely for clinical worsening, suicidality, or unusual changes in behavior. Anafranil is not approved for use in pediatric patients under 10 years of age.

Additional safety considerations include:

  • Seizure Risk: Anafranil lowers the seizure threshold in a dose-dependent manner. Caution is required in patients with a history of seizures or conditions predisposing to seizures.
  • Cardiovascular Risks: May cause orthostatic hypotension, tachycardia, or conduction abnormalities (including QT prolongation). Use with extreme caution in patients with underlying cardiovascular disease or post-myocardial infarction.
  • Special Populations: Elderly patients are particularly sensitive to anticholinergic, sedative, and cardiovascular side effects. In pregnancy, use only if potential benefits justify potential risks to the fetus; clomipramine is excreted into human milk.

If you skip a dose

If a dose of Anafranil is missed, it should be taken as soon as remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely, resuming the regular dosing timeline. Patients should never double the dose or take extra medication to make up for a missed capsule, as this increases the risk of adverse anticholinergic toxicity and seizures.

Storage and expiration

Anafranil capsules should be stored at controlled room temperature, between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). The medication must be kept in a tightly closed container, protected from excessive moisture, heat, and direct light. Store securely out of the reach of children and pets. Do not use capsules past the expiration date printed on the original packaging.

Common questions

Does Anafranil cause drowsiness or affect daily activities?

Yes, sedation and somnolence are common side effects of Anafranil due to its central H1-histamine receptor blockade. Patients should assess how the medication affects them before driving, operating heavy machinery, or performing tasks requiring high mental alertness. Taking the primary daily dose at bedtime, if advised by a physician, can help reduce daytime impairment.

Why does it take several weeks for Anafranil to relieve OCD symptoms?

While the biochemical inhibition of neurotransmitter reuptake occurs within hours of ingestion, downstream physiological adaptations in neural circuitry and receptor sensitivity require time. Clinical improvement in obsessive-compulsive symptoms typically manifests over 2 to 6 weeks, with maximal therapeutic benefits often occurring after several months of steady treatment.

Is it safe to stop taking Anafranil suddenly?

Abrupt withdrawal of Anafranil is not recommended. Sudden cessation can precipitate cholinergic rebound and withdrawal symptoms, including nausea, headache, dizziness, vivid dreams, anxiety, and sleep disturbances. Tapering the dosage incrementally under medical supervision minimizes these risks.

Can Anafranil cause issues with heart rhythm?

Tricyclic antidepressants, including clomipramine, can alter cardiac conduction velocity and prolong the QT interval, potentially leading to dysrhythmias. Patients with pre-existing heart conditions, electrolyte imbalances, or those taking other QT-prolonging agents require careful cardiac monitoring prior to and during treatment.

What should be done if an accidental overdose occurs?

An overdose of Anafranil is a critical medical emergency that can rapidly cause severe cardiac arrhythmias, low blood pressure, severe confusion, convulsions, and coma. In the event of suspected overdose, immediate emergency medical evaluation and contact with a local poison control center are mandatory.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

10 mg

,

25mg

,

50mg

,

75mg

Package

30 tabs

,

30 pills

,

60 pills

,

60 tabs

,

90 pills

,

90 tabs

,

120 pills

,

120 tabs

,

180 pills

,

180 tabs

,

270 pills

,

360 pills

,

360 tabs

Ενεργός Ουσία